Hybrid 2-[(18)F] FDG PET/MRI in premanifest Huntington’s disease gene-expansion carriers: The significance of partial volume correction

BACKGROUND: Huntington’s disease (HD) is an inherited, progressive neurodegenerative disease that has no cure. Striatal atrophy and hypometabolism has been described in HD as far as 15 years before clinical onset and therefore structural and functional imaging biomarkers are the most applied biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellem, Marie N. N., Vinther-Jensen, Tua, Anderberg, Lasse, Budtz-Jørgensen, Esben, Hjermind, Lena E., Larsen, Vibeke Andrée, Nielsen, Jørgen E., Law, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195345/
https://www.ncbi.nlm.nih.gov/pubmed/34115782
http://dx.doi.org/10.1371/journal.pone.0252683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195345/
https://www.ncbi.nlm.nih.gov/pubmed/34115782
http://dx.doi.org/10.1371/journal.pone.0252683

Ejemplares similares